Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis

J Immunol. 1999 Oct 15;163(8):4182-91.

Abstract

Human normal and malignant T cells cease to proliferate, down-modulate Bcl-2 expression, and undergo apoptosis when cultured in the presence of NO-donor compounds (sodium nitroprusside and NOC12) for 48 h. At 72 h, cells that evade apoptosis start to proliferate again, overexpress both chains of the IFN-gammaR, and thus become susceptible to apoptosis in the presence of IFN-gamma. By contrast, in the presence of IFN-gamma, no apoptosis, but an increase of proliferation was displayed by control cultures of T cells not exposed to NO and not overexpressing IFN-gammaR chains. The NO-induced cell surface overexpression of IFN-gammaR chains did not affect the transduction of IFN-gamma-mediated signals, as shown by the expression of the transcription factor IFN regulatory factor 1 (IRF-1). However, transduction of these signals was quantitatively modified, because IFN-gamma induces enhanced levels of caspase-1 effector death in NO-treated cells. These findings identify NO as one of the environmental factors that critically govern the response of T cells to IFN-gamma. By inducing the overexpression of IFN-gammaR chains, NO decides whether IFN-gamma promotes cell proliferation or the induction of apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis / immunology*
  • Cell Division / drug effects
  • Cell Division / immunology
  • Cells, Cultured
  • DNA-Binding Proteins / biosynthesis
  • Dose-Response Relationship, Immunologic
  • Growth Inhibitors / metabolism
  • Growth Inhibitors / pharmacology
  • Growth Inhibitors / physiology*
  • Humans
  • Interferon Regulatory Factor-1
  • Interferon gamma Receptor
  • Interferon-gamma / metabolism
  • Interferon-gamma / pharmacology
  • Interferon-gamma / physiology*
  • Lymphoma, T-Cell / pathology
  • Nitric Oxide / metabolism
  • Nitric Oxide / pharmacology
  • Nitric Oxide / physiology*
  • Nitric Oxide Donors / metabolism
  • Nitroprusside / pharmacology
  • Nitroso Compounds / pharmacology
  • Phosphoproteins / biosynthesis
  • Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Receptors, Interferon / biosynthesis
  • Receptors, Interleukin-2 / biosynthesis
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / metabolism
  • T-Lymphocytes / pathology
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • DNA-Binding Proteins
  • Growth Inhibitors
  • IRF1 protein, human
  • Interferon Regulatory Factor-1
  • NOC 12
  • Nitric Oxide Donors
  • Nitroso Compounds
  • Phosphoproteins
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Interferon
  • Receptors, Interleukin-2
  • Nitroprusside
  • Nitric Oxide
  • Interferon-gamma